Search clinical trials for: MET∆ex14

Total 43451 results

Sun Yat-sen University
The First Affiliated Hospital with Nanjing Medical University; Guangdong Provincial... and other collaborators

Completed

Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes

Type 2 Diabetes Mellitus

China
Riphah International University

Completed

Effects of Back Muscles Endurance Training in Patients With Chronic Mechanical Low Back Pain

Mechanical Low Back Pain | Muscle Stretching Exercises | Paraspinal Muscles

Pakistan
U&I Corporation

Completed

The Efficacy and Safety of Magnesium Alloy Screw as a Novel Bioabsorbable Material in Patients Due to Hand Fractures

Hand Fractures
Foundation University Islamabad

Completed

Comparison of Muscle Specific and Movement Specific Muscle Energy Technique in the Management of Mechanical Neck Pain: a Randomized Controlled Trial.

Neck Pain

Pakistan
Amsterdam UMC, location VUmc
National MS Foundation, The Netherlands; Voeding Leeft

Recruiting

Lifestyle Intervention for Patients With Multiple Sclerosis (LIMS)

Multiple Sclerosis

Netherlands
National University Hospital, Singapore

Not yet recruiting

A Biomarker-implemented Clinical Study Evaluating Mutations in MET and TP53 in a Population of Treatment-refractory Squamous Cell Carcinoma

Squamous Cell Carcinoma

Singapore
Chang Gung University

Completed

Effects of Soft Tissue Mobilization of Neck Muscles in Individuals With Myogenous Temporomandibular Disorders: Muscle Energy Technique and Strain-counterstrain

Myogenous Temporomandibular Disorders (mTMD)

Taiwan
NuBiyota

Completed

Safety and Efficacy of Microbial Ecosystem Therapeutic-2 (MET-2) in Patients With Ulcerative Colitis (UC)

Ulcerative Colitis

Canada
Elcelyx Therapeutics, Inc.

Completed

Assessing the Efficacy, Safety, and Tolerability of Met DR in Subjects With T2DM Over 12 Weeks

Type 2 Diabetes Mellitus
Centre Oscar Lambret

Completed

Study of the Expression of Met Receptor Fragments in Non Small Cell Lung Cancers (MetLung)

Non Small Cell Lung Cancer

France
October 6 University

Completed

Effect of Foot Muscle Energy Technique in Patients With Diabetic Neuropathy

Diabetic Neuropathies

Egypt
Otologics LLC

Unknown

Middle-Ear Implant With MET V Transducer (Aka MET V System)

Mixed Conductive and Sensorineural Hearing Loss, Bilateral
University Health Network, Toronto
NuBiyota

Active, not recruiting

Role of Microbiome as a Biomarkers in Locoregionally-Advanced Oropharyngeal Squamous Cell Carcinoma 2 (ROMA LA-OPSCC2)

Head and Neck Squamous Cell Carcinoma

Canada
argenx

Completed

A Phase 1b Study of ARGX-111 in Patients With Advanced Cancer.

Cancer

Belgium
Guangdong Provincial People's Hospital
Shanghai Junshi Bioscience Co., Ltd.

Recruiting

Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC

Non-Small Cell Lung Cancer | BRAF V600 Mutation | MET Amplification | MET Exon 14 Skipping Mutation | RET Driver Mutation | Erb-B2 Receptor Tyrosine Kinase Exon 20 Mutation

China
Elcelyx Therapeutics, Inc.

Completed

Assessing the Behavior of Met DR in Subjects With Kidney Dysfunction

Renal Insufficiency
Obafemi Awolowo University

Completed

Muscle Energy Technique and Static Stretching on Pain Intensity and Functional Disability in Patients With Mechanical Neck Pain (MET&SSinNckp)

Neck Pain

Nigeria
UConn Health
National Institute on Drug Abuse (NIDA)

Completed

A Pilot SMART Design for Pathological Gamblers (SMART)

Pathological Gambling

United States
King Saud University
Shah Physiotherapy Center, Delhi, India

Completed

Efficacy of Combination Therapies on Neck Pain & Muscle Tenderness in Patients With Upper Trapezius MTrPs

Myofascial Trigger Point Pain

Saudi Arabia
Timothy Burns, MD, PHD
Novartis

Withdrawn

Central Nervous System Efficacy of Capmatinib in NSCLC With Brain Metastases With cfDNA Positive MET Alterations

Non-small Cell Lung Cancer

United States
St. Louis University
VA St. Louis Health Care System

Completed

Exercise: Addressing Stress in Relapse Prevention for Substance Use Disorders

Substance Use Disorders

United States
University Health Network, Toronto
Pfizer

Recruiting

Study of Crizotinib for ROS1 and MET Activated Lung Cancer

Non-squamous Non-small-cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | ROS1 Gene Rearrangement | MET Activating Mutation | MET Amplification

Canada
Cairo University

Not yet recruiting

Pilate Mat Exercise Versus Muscle Energy Technique on Chronic Non Specific Low Back Pain (MET-LBP)

Chronic Non Specific Low Back Pain
University Hospital, Basel, Switzerland

Completed

Validity of the MET-REPAIR Questionnaire (MET-REPAIR Val)

Anesthesia

Switzerland
Dartmouth-Hitchcock Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Targeting Tobacco Cessation During Treatment for Cannabis Use Disorders

Cannabis Dependence

United States
Mirati Therapeutics Inc.

Completed

Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

Non-Small Cell Lung Cancer

United States, Korea, Republic of, Hungary, United Kingdom, Italy, Australia, Taiwan, Poland, Canada
Athira Pharma
Biotrial Inc.; Alturas Analytics, Inc.

Completed

Safety, Tolerability, and Pharmacokinetics Study of ATH-1020

Healthy Volunteers

United States
Laboratorios Silanes S.A. de C.V.

Suspended

Efficacy and Safety of Metformin Glycinate Compared to Metformin Hydrochloride on the Progression of Type 2 Diabetes (COMETII)

Type 2 Diabetes

Mexico
UConn Health
Donaghue Medical Research Foundation

Completed

Gambling and Brief Interventions

Gambling

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck

Head and Neck Cancer

United States
Samsung Medical Center

Completed

A Pilot Study of Crizotinib in Patients With c-MET Positive Gastric Adenocarcinoma as a Third-line Chemotherapy

c-MET Positive Gastric Cancer

Korea, Republic of
Riphah International University

Completed

Comparison of Mobilization and MET Post-Traumatic Elbow Stiffness (MET)

Elbow Fracture

Pakistan
Dartmouth-Hitchcock Medical Center
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Family Based Contingency Management for Adolescent Alcohol Abuse

Alcohol Abuse

United States
Novartis Pharmaceuticals

Withdrawn

Study of Oral cMET Inhibitor INC280 in Chinese Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer (NSCLC)

Carcinoma | Non-Small-Cell Lung Cancer
Duke University
Prostate Cancer Foundation; Janssen Diagnostics, LLC

Completed

Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)

Renal Cell Carcinoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Prostate Cancer | Bladder Cancer | Non-small Cell Lung Cancer | Advanced MET Amplified Solid Tumor

United States
University Health Network, Toronto
NuBiyota

Active, not recruiting

Feasibility Study of Microbial Ecosystem Therapeutics (MET-4) to Evaluate Effects of Fecal Microbiome in Patients on ImmunOtherapy (MET4-IO)

All Solid Tumors

Canada
Assistance Publique - Hôpitaux de Paris

Completed

Discriminant Validity of the Multiple Errands Test in Schizophrenia (VALITEM)

Schizophrenia

France
NuBiyota
Glycemic Index Laboratories, Inc

Completed

Safety and Efficacy of MET-3 in Obese Human Subjects

Obesity

Canada
Haihe Biopharma Co., Ltd.

Unknown

Glumetinib Combined With Osimertinib in the Treatment of Relapsed and Metastatic Non-small Cell Lung Cancer Patients Who Failed to Receive EGFR Inhibitors

Negative T790M Mutation and Met Amplification

China
Avistone Biotechnology Co., Ltd.

Recruiting

Vebreltinib Plus PLB1004 in EGFR-mutated, Advanced NSCLC With MET Amplification or MET Overexpression Following EGFR-TKI

Non-Small-Cell Lung Cancer

China
AbbVie

Active, not recruiting

Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

United States, Australia, Belgium, Bulgaria, Canada, China, Czechia, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Puerto Rico, Romania, Russian Federation, Spain, Switzerland and more
Novartis Pharmaceuticals

Active, not recruiting

Phase II of Neoadjuvant and Adjuvant Capmatinib in NSCLC (Geometry-N)

Non-small Cell Lung Cancer

United States
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

Study of HS-10241 in Combination With Almonertinib in Patients With Locally Advanced or Metastatic NSCLC

Non Small Cell Lung Cancer

China
Turning Point Therapeutics, Inc.

Active, not recruiting

Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET (SHIELD-1)

Advanced Solid Tumor | Metastatic Solid Tumors | MET Gene Alterations

United States, France, Korea, Democratic People's Republic of, Korea, Republic of, Spain
National Cancer Institute (NCI)

Completed

Tivantinib in Treating Patients With Recurrent or Metastatic Breast Cancer

Stage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma

United States
Kaiser Permanente
Garfield Memorial Fund

Completed

Multidisciplinary Inpatient Palliative Care Intervention

Liver Failure | Acquired Immunodeficiency Syndrome | Stroke | Pneumonia | Diabetes Mellitus | Cancer | Pulmonary Disease, Chronic Obstructive | Respiratory Failure | Renal Failure | Dementia | Kidney Failure, Chronic | Coronary Arteriosclerosis | Cerebrovascular Accident | Failure to Thrive | Heart Failure, Congestive

United States
Istituto Clinico Humanitas

Completed

Molecular Features Predicting Response/Resistance to Trastuzumab in Metastatic Breast Cancer Patients

Breast Cancer

Italy
University of California, Los Angeles

Completed

Varenicline for Methamphetamine Dependence

Substance Abuse | Methamphetamine Dependence | Methamphetamine Abuse

United States
Novartis Pharmaceuticals

Completed

Study of Oral cMET Inhibitor INC280 in Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1)

Carcinoma, Non-Small-Cell Lung

Italy, Spain, Germany, Japan, Taiwan, Belgium, Netherlands, Singapore, Argentina, France, Israel, Sweden, Korea, Republic of, Lebanon, United Kingdom, United States, Austria, Mexico, Norway, Russian Federation
University Health Network, Toronto

Not yet recruiting

Antimicrobial Resistant Organism Decolonization After Microbiome Perturbation (ARO-DECAMP)

Microbial Colonization | Antibiotic Resistant Infection | Gram-negative Bacteremia

Canada

Search clinical trials for: MET∆ex14

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations